Cipla Gains Nearly 5% On Settlement of US Patent Litigation
Cipla share price jumps 5%: The pharma major has announced settlement of its patent litigation with Celgene Corporation, a wholly-owned subsidiary of Bristol Myers Squibb, in the United States
No comments:
Post a Comment